What it’s for
- Selected stages of age-related macular degeneration
A specific antioxidant and mineral formula studied for age-related macular degeneration.
Purpose, evidence and practical considerations.
The tested formula can reduce progression risk for eligible patients. It is not proven to prevent AMD in people without the relevant eye findings and should follow an eye-care assessment.
Confidence: strong
AREDS2 is not intended for everyone. High-dose zinc and vitamin E can interact with health conditions or medicines; an eye-care professional should determine whether a person's AMD stage matches the studied population.
AREDS2 supplies antioxidant micronutrients and zinc at the doses tested in people at elevated risk of progression to advanced age-related macular degeneration.
Regulatory status: dietary supplement formula; not an FDA-approved treatment
The evidence on this page does not automatically apply to:
How people use it, with their schedules, context and original sources.
with first meal around 2–3 p.m.
ocular / presbyopia experiment with low downside
Amount and timing patterns reported in public protocols; these are observations, not instructions. Private and hidden usage is excluded.
Brand variants reported in public protocols. Private entries are excluded, and inclusion is not an endorsement.
These share a protocol with this intervention. This does not establish that they work together or are suitable alternatives.